Justin W. Yorke - Dec 31, 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role: Director
Signature: /s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol: PCSA
Transactions as of: Dec 31, 2022
Transactions value $: $0
Form type: 4
Date filed: 1/4/2023, 04:49 PM
Previous filing: Jan 4, 2023
Next filing: May 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCSA	Common Stock	Award		+18.2K	+122.32%		33.1K	Dec 31, 2022	Direct	F1
holding	PCSA	Common Stock						533K	Dec 31, 2022	By Richland Fund, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCSA	Restricted Stock	Award	$0	+30K		$0.00	30K	Jan 1, 2023	Common Stock	30K	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Vesting of time-based restricted shares.
F2	The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.